Maimendong decoction and its active ingredient, ophiopogonin D, alleviate bleomycin-induced pulmonary fibrosis by regulating the behavior of lung fibroblasts
The results of this study indicate that MMDD and its active component, OP-D, can treat IPF by targeting the proliferation of lung fibroblasts.
Authors
- Chunmei Li
- Shengchuan Bao (ORCID: https://orcid.org/0000-0003-3742-0220)
- Xinyue Zhang
- Mingjie Yang
- Yushan Liu (ORCID: https://orcid.org/0000-0002-2799-9542)
- Jingtao Li (ORCID: https://orcid.org/0000-0002-0774-194X)
- Yilin Zhang (ORCID: https://orcid.org/0000-0001-5390-4116)
- Shu-Guang Yan
- Shusen Yang (ORCID: https://orcid.org/0000-0002-7881-0009)
Institutions
- Shandong University of Traditional Chinese Medicine (CN)
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Affiliated Hospital of Shaanxi University of Chinese Medicine (CN)
- Shaanxi University of Chinese Medicine (CN)
- Wuhan Sports University (CN)
Publication Details
- Journal
- Chinese Medicine
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1186/s13020-025-01206-x
- Citations
- 1
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 1.52